ImmunoGen Announces Webcast of Presentation at Upcoming Jefferies Virtual Healthcare Conference

Rhea-AI Summary

ImmunoGen Inc. (Nasdaq: IMGN) announced that CFO Susan Altschuller and CMO Anna Berkenblit will participate in a fireside chat at the Jefferies Virtual Healthcare Conference on June 2, 2021, at 9:30 am ET. A live webcast will be available through the Investors and Media section of their website, with a replay to follow. ImmunoGen is dedicated to developing advanced antibody-drug conjugates (ADCs) aimed at improving cancer patient outcomes by offering targeted therapies with enhanced efficacy and tolerability.

Positive

• Participation in a prominent healthcare conference may enhance visibility and investor interest.
• Focus on developing advanced ADCs reflects a commitment to innovation in cancer treatment.

Negative

• None.

ImmunoGen Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that Susan Altschuller, Chief Financial Officer, and Anna Berkenblit, Chief Medical Officer, will participate in a fireside chat at the upcoming Jefferies Virtual Healthcare Conference. The presentation is scheduled for June 2, 2021 at 9:30am ET.

A webcast of the presentation will be accessible through the Investors and Media section of the Company's website on www.immunogen.com. Following the live webcast, a replay will be available at the same location.

ABOUT IMMUNOGEN

ImmunoGen is developing the next generation of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. By generating targeted therapies with enhanced anti-tumor activity and favorable tolerability profiles, we aim to disrupt the progression of cancer and offer our patients more good days. We call this our commitment to TARGET A BETTER NOW™.

Learn more about who we are, what we do, and how we do it at www.immunogen.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210520005073/en/

FAQ

What is the date of the Jefferies Virtual Healthcare Conference for ImmunoGen?

ImmunoGen will participate in the Jefferies Virtual Healthcare Conference on June 2, 2021.

Who will represent ImmunoGen at the conference?

CFO Susan Altschuller and CMO Anna Berkenblit will represent ImmunoGen at the conference.

Where can I watch the ImmunoGen conference presentation?

The presentation will be available via webcast on the Investors and Media section of ImmunoGen's website.

What is ImmunoGen's focus in cancer treatment?

ImmunoGen focuses on developing advanced antibody-drug conjugates (ADCs) to improve cancer treatment outcomes.